{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"AI Proteins signs Astellas agreement with over $400 million in potential payments","author_name":"techandbusiness.org · AI","thumbnail_url":"https://s.yimg.com/lo/mysterio/api/f9b6d008de7623193b17d546b85e6552d57daf4990d8b1f9243a34ab88323ff8/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fbusiness-wire.com%2F174c39861cb8e5e27f7b413e09684074.jpg","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · AI</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/m6_T9B-QCiAHgeYipwyO9h\" style=\"color:#fff;text-decoration:none;\">AI Proteins signs Astellas agreement with over $400 million in potential payments</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">AI Proteins said it signed a research and licensing agreement with an Astellas Pharma affiliate that makes it eligible for over $400 million in upfront and milestone payments, plus royalties on result...</p>\n    </blockquote>"}